This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.
LATEST KEY DEVELOPMENTS
Competition & State Aid
- European Court of Auditors reviews risks, challenges and opportunities in the EU's economic policy response to the COVID-19 crisis
- EU approves new and amended Member State measures to support the economy
Trade / Export Controls
- No noteworthy developments for this issue
Medicines, Medical Devices, and Personal Protective Equipment
- European medicines agencies network presents Strategy to 2025
- EMA further expands transparency in relation to COVID-19 medicinal products
- EMA commences evaluation for granting marketing authorizations for two COVID-19 vaccines
- EMA starts rolling review of COVID-19 vaccine
Cybersecurity, Privacy & Data Protection
- No noteworthy developments for this issue
To view the full article please click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.